Innovate UK, the people who funded the development of Noctura 400, have published a new video about the revolutionary treatment for degenerative sight-threatening conditions caused by age and diabetes. Watch the video here → British artist turned entrepreneur develops new technology to treat one of the main causes of blindness, with support from Innovate UK. […]
“PolyPhotonix is one of the UK’s most exciting life science companies and helps put the North East at the forefront of scientific innovation.”
“I’m visiting PolyPhotonix in Sedgefield, one of the UK’s most exciting life science companies, who have developed a unique eye mask to improve the sight of diabetics across the globe.”
The event, on March 10, has attracted key speaker Dr Ruth McKernan CBE, chief executive of Innovate UK as well as Dr Graham Hillier from NETPark-based CPI and PolyPhotonix chief executive, Richard Kirk.
PolyPhotonix will be taking part at the life sciences expo at the London Stock Exchange next week.
We spoke to Richard Kirk, the founder of PolyPhotonix, a Sedgefield-based company providing revolutionary treatment for debilitating eye disease
As we look back on the medtech developments of 2015 there’s definitely a sense that we’re living through revolutionary times.
The Sedgefield business has been nominated by Justin Urquhart-Stewart, a regular TV market commentator and co-founder of Seven Investment Management
North East developer of sleep masks to treat diabetic retinopathy made the move to support the growth of its product
George Osborne will update the nation on the government’s plans for the economy tomorrow, delivering The Autumn Statement alongside a Spending Review. Read what Richard Kirk along with other North East businesses want to see ahead of Budget Day.